Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 121 mln. 82,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,39 mln. -24,05 mln. | Nettowinst (verlies) 2021 | -52 mln. -70,78 mln. -48,09 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 681K 463K | Nettoliquiditeiten 2021 | 1,77 mln. 2,41 mln. 1,64 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,67% | 5,41 mld. | |
-35,93% | 3,52 mld. | |
-6,69% | 2,96 mld. | |
-27,73% | 2,6 mld. | |
-11,46% | 2,29 mld. | |
+38,57% | 1,89 mld. | |
+38,46% | 1,47 mld. | |
-16,41% | 1,43 mld. | |
+42,86% | 1,36 mld. |